Ionis Pharmaceuticals | IONS - Gross Profit On Sales

Stock Price
86.50
Daily Change
3.02 3.62%
Monthly
4.00%
Yearly
175.48%
Q1 Forecast
80.12

Ionis Pharmaceuticals reported $155M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Agios Pharmaceuticals USD 11.2M 448K Sep/2025
Alnylam Pharmaceuticals USD 1.05B 418.14M Sep/2025
Arrowhead Research USD 256.47M 228.7M Sep/2025
Astellas Pharma JPY 456.81B 38.02B Dec/2025
BioMarin Pharmaceutical USD 631.2M 39.27M Sep/2025
Celltrion KRW 626.11B 81.75B Sep/2025
Cspc Pharmaceutical CNY 4.34B 333.68M Sep/2025
Divis Laboratories Ltd INR 14.54B 1.5B Jun/2025
Exelixis USD 579.18M 30.39M Sep/2025
Halozyme Therapeutics USD 281.77M 2.41M Sep/2025
Ionis Pharmaceuticals USD 155M 293M Sep/2025
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Knight Therapeutics CAD 44.83M 9.96M Jun/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Moderna USD 809M 791M Sep/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Neurocrine Biosciences USD 780.9M 104.7M Sep/2025
Novartis USD 10.82B 695M Sep/2025
OPKO Health USD 46.89M 27.83M Sep/2025
Organigram Holdings CAD 31.84M 23.88M Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Pharma Mar EUR 33.36M 20.25M Sep/2025
PTC Therapeutics USD 187.69M 24.3M Sep/2025
Qiagen NV USD 344.8M 10.51M Sep/2025
Regeneron Pharmaceuticals USD 3.3B 67M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sarepta Therapeutics USD 247.9M 209.96M Sep/2025
Sartorius EUR 393.2M 23M Sep/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Tilray USD 67.63M 15.62M Mar/2025
Ultragenyx Pharmaceutical USD 131.94M 11.55M Sep/2025
Vertex Pharmaceuticals USD 2.66B 104.4M Sep/2025
Zz Pientze Pharmaceu CNY 296.13M 1.1B Jun/2025